Literature DB >> 30261197

A regulatory view on novel methodologies and context of use of biomarkers.

M B Tome1, M T Isaac2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30261197     DOI： 10.1016/j.neubiorev.2018.09.015

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN： 0149-7634            Impact factor:   8.989


× No keyword cloud information.
  1 in total

Review 1.  Do DSM classifications help or hinder
drug development?
.

Authors:  Michael Davidson; Cristian Gabos-Grecu
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.